Prevalence of primary immune thrombocytopenia in Oklahoma
Open Access
- 14 May 2012
- journal article
- research article
- Published by Wiley in American Journal of Hematology
- Vol. 87 (9) , 848-852
Abstract
To determine the prevalence of immune thrombocytopenia (ITP) in Oklahoma regardless of age, clinical characteristics, insurance status, and source of health care. Patients with ITP were identified by the administrative code ICD‐9‐CM 287.3 in Oklahoma hematologists' offices for a 2‐year period, 2003–2004. Prevalence was estimated separately for children (<16 years old) and adults because of their distinct clinical characteristics. Oklahoma census data for 2000 was used as the denominator. Eighty‐seven (94%) of 93 eligible Oklahoma hematologists participated; 620 patients with ITP were identified. The average annual prevalences were as follows: 8.1 (95% CI: 6.7–9.5) per 100,000 children, 12.1 (95% CI: 11.1–13.0) per 100,000 adults, and 11.2 (95% CI: 10.4–12.0) per 100,000 population. Among children and adults less than age 70 years, the prevalence was greater among women. Among adults aged 70 years and older, the prevalence was greater among men. The highest prevalence of ITP was among men age 80 years and older. These data document for the first time the prevalence of ITP regardless of age, clinical characteristics, insurance status, and source of health care. The methodology developed for this prevalence analysis may be adaptable for epidemiologic studies of other uncommon disorders which lack specific diagnostic criteria and are treated primarily by medical specialists. Am. J. Hematol. 2012.Keywords
This publication has 27 references indexed in Scilit:
- Referral of patients with thrombocytopenia from primary care clinicians to hematologistsBlood, 2009
- Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working groupBlood, 2009
- Improved quality of life for romiplostim‐treated patients with chronic immune thrombocytopenic purpura: results from two randomized, placebo‐controlled trialsBritish Journal of Haematology, 2009
- Health-related quality of life of immune thrombocytopenic purpura patients: results from a web-based surveyCurrent Medical Research and Opinion, 2008
- Accuracy of identification of patients with immune thrombocytopenic purpura through administrative records: A data validation studyAmerican Journal of Hematology, 2003
- Clinically significant newly presenting autoimmune thrombocytopenic purpura in adults: a prospective study of a population‐based cohort of 245 patientsBritish Journal of Haematology, 2003
- Idiopathic thrombocytopenic purpura diagnosed during the second decade of lifeThe Journal of Pediatrics, 2002
- Morbidity and mortality in adults with idiopathic thrombocytopenic purpuraBlood, 2001
- IMMUNE THROMBOCYTOPENIC PURPURA IN CHILDHOOD IN NORWAY: A Prospective, Population-Based RegistrationPediatric Hematology and Oncology, 2000
- Chronic idiopathic thrombocytopenic purpura: incidence, treatment, and outcome.Archives of Disease in Childhood, 1995